Chief Executive Officer Gupta Amit sold $332,682 worth of shares (101,422 units at $3.28) and converted options into 250,000 shares, increasing direct ownership by 69% to 364,072 units (SEC Form 4)

$CDLX
Computer Software: Programming Data Processing
Technology
Get the next $CDLX alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gupta Amit

(Last) (First) (Middle)
675 PONCE DE LEON AVENUE NE
SUITE 4100

(Street)
ATLANTA GA 30308

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/16/2025 M 125,000 A (1) 340,494 D
Common Stock 02/16/2025 M 125,000 A (1) 465,494 D
Common Stock 02/18/2025 S 46,857(2) D $3.398(3) 418,637 D
Common Stock 02/19/2025 S 54,565(2) D $3.179(4) 364,072 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 02/16/2025 M 125,000 (5) (5) Common Stock 125,000 $0 375,000 D
Restricted Stock Units (1) 02/16/2025 M 125,000 (6) (6) Common Stock 125,000 $0 375,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
2. Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on February 16, 2025. The Reporting Person did not sell shares for any other purpose.
3. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.285 to $3.515, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (3) and (4) in this Form 4.
4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.31, inclusive.
5. The RSU award is for 500,000 shares that were granted on August 21, 2024. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.
6. The RSU award is for 500,000 shares that were granted on January 29, 2025. The RSUs will vest and have vested in four installments over a period of 24 months following August 16, 2024, the date the Reporting Person assumed the role of Chief Executive Officer, with 25% of the RSUs vesting on each of the six-, twelve-, eighteen- and twenty-four-month anniversaries, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Remarks:
/s/ Nick Lynton, Attorney-in-Fact 02/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $CDLX alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CDLX

DatePrice TargetRatingAnalyst
10/11/2024$4.00In-line
Evercore ISI
8/16/2024$5.00Outperform → Market Perform
Northland Capital
8/15/2024$4.00 → $3.50Neutral → Underperform
BofA Securities
8/8/2024Buy → Hold
Craig Hallum
8/8/2024Buy → Hold
Needham
8/8/2024$18.00 → $5.00Buy → Hold
Lake Street
6/20/2024$11.00Neutral
BofA Securities
6/18/2024$14.00Outperform
Northland Capital
More analyst ratings

$CDLX
Press Releases

Fastest customizable press release news feed in the world

See more
  • Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results

    Cardlytics, Inc. (NASDAQ:CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2024. "While 2024 was a challenging year for Cardlytics, we nevertheless planted the seeds and refocused our efforts to get back on track for growth this year," said Amit Gupta, CEO of Cardlytics. "We remain grounded in our vision for long-term and sustainable growth. We are focused on strengthening our competitive moat through our efforts to modernize our platform, enhance our product and tech capabilities, and expand our network of partners and advertisers." "In 2025, we are focused on delivering sequential improvements and positive Adjusted EBITDA," said Alexis DeSie

    $CDLX
    Computer Software: Programming Data Processing
    Technology
  • Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Cardlytics, Inc. (NASDAQ:CDLX) today announced that on February 26, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 225,800 restricted stock units of Cardlytics to 18 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the "2022 Inducement Plan"). For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees' con

    $CDLX
    Computer Software: Programming Data Processing
    Technology
  • Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release

    Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2024 will be released on March 12, 2025, after market close. Conference Call Details: When: March 12, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial (+1) 800-549-8228 and use Conference ID: 91460. About Cardlytics Cardlytics (NASDAQ:CDLX) is a digital advertising platform. We partner with financ

    $CDLX
    Computer Software: Programming Data Processing
    Technology

$CDLX
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CDLX
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$CDLX
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CDLX
SEC Filings

See more

$CDLX
Leadership Updates

Live Leadership Updates

See more
  • 23andMe Appoints Three New Independent Directors to Board

    SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company's Board of Directors (the "Board"), effective on October 28, 2024. Each of Mr. Fernandez, Mr. Frankola, and Mr. Jensen have been appointed to serve as members of the Board's Audit Committee and Compensation Committee, with Mr. Fernandez serving as the Chair of the Audit Committee and Mr. Jensen serving as the Chair of the Compensation Committee. In additio

    $ANSS
    $CDLX
    $LSCC
    $ME
    Computer Software: Prepackaged Software
    Technology
    Computer Software: Programming Data Processing
    Semiconductors
  • Cardlytics Appoints Amit Gupta as CEO

    ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ:CDLX), a digital advertising platform, today announced that the Board of Directors has appointed Amit Gupta, Chief Operating Officer and General Manager of Bridg, as its next Chief Executive Officer of Cardlytics, effective August 16, 2024. He will also join the Cardlytics Board of Directors on that date. Mr. Gupta will succeed Karim Temsamani, who is stepping down as Chief Executive Officer and from the Board of Directors to pursue another professional opportunity. "Amit is the right person to lead Cardlytics in its next stage of growth," said Jack Klinck, Chair of the Cardlytics Board. "For the last year and a half, Ami

    $CDLX
    Computer Software: Programming Data Processing
    Technology
  • Liane Hornsey Appointed to Cardlytics Board of Directors

    ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ:CDLX), a digital advertising platform, is excited to announce the appointment of Liane Hornsey to its Board of Directors. In connection with her appointment to the Board of Directors, Hornsey was also appointed to the Board's Compensation Committee, and she will assume the role of Compensation Committee Chairperson upon Cardlytics' upcoming Annual Meeting of Stockholders in May 2024. Hornsey, who is currently Executive Vice President and Advisor to the CEO at Palo Alto Networks, is widely recognized as one of the world's top practitioners in people operations, organizational development and leadership development. She jo

    $CDLX
    Computer Software: Programming Data Processing
    Technology

$CDLX
Financials

Live finance-specific insights

See more
  • Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results

    Cardlytics, Inc. (NASDAQ:CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2024. "While 2024 was a challenging year for Cardlytics, we nevertheless planted the seeds and refocused our efforts to get back on track for growth this year," said Amit Gupta, CEO of Cardlytics. "We remain grounded in our vision for long-term and sustainable growth. We are focused on strengthening our competitive moat through our efforts to modernize our platform, enhance our product and tech capabilities, and expand our network of partners and advertisers." "In 2025, we are focused on delivering sequential improvements and positive Adjusted EBITDA," said Alexis DeSie

    $CDLX
    Computer Software: Programming Data Processing
    Technology
  • Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release

    Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2024 will be released on March 12, 2025, after market close. Conference Call Details: When: March 12, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial (+1) 800-549-8228 and use Conference ID: 91460. About Cardlytics Cardlytics (NASDAQ:CDLX) is a digital advertising platform. We partner with financ

    $CDLX
    Computer Software: Programming Data Processing
    Technology
  • Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release

    ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ:CDLX), an advertising platform in banks' digital channels, today announced that its financial results for the third quarter ending September 30, 2024 will be released on November 6, 2024, after market close. The results will be discussed via conference call at 5:00 PM ET / 2:00 PM PT. The company invites investors to join a live audio webcast at http://ir.cardlytics.com/ or to dial-in by registering at this link. A replay will be available on the Cardlytics Investor Relations website at http://ir.cardlytics.com/. About Cardlytics Cardlytics (NASDAQ:CDLX) is a digital advertising platform. We partner with financial insti

    $CDLX
    Computer Software: Programming Data Processing
    Technology

$CDLX
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more